Article

Some Insurers Refuse To Cover Contraceptives, Despite Health Law Requirement

How much leeway do employers and insurers have in deciding whether they'll cover contraceptives without charge and in determining which methods make the cut?

How much leeway do employers and insurers have in deciding whether they’ll cover contraceptives without charge and in determining which methods make the cut?

Not much, as it turns out, but that hasn’t stopped some from trying.

Kaiser Health News readers still write in regularly describing battles they’re waging to get the birth control coverage they’re entitled to.

Source: Kaiser Health News

Read the full story:

http://bit.ly/1ohWHNe

Related Videos
4 experts are featured in this series.
Steven Daniel Daveluy, MD, FAAD
5 experts are featured in this series
3 experts are featured in this series.
4 experts are featured in this series.
3 experts are featured in this series.
1 expert is featured in this series.
5 experts are featured in this series
Related Content
The investigators concluded that epidemiological inequity in CKD and cardiovascular disease remains an important issue that requires further study of potential interventions. | Image credit: filins - stock.adobe.com
March 22nd 2025

Disparities in CKD-Associated Cardiac Arrest Across Demographics

Jared Kaltwasser
Non-Hispanic Black populations face the highest risk of death from chronic kidney disease (CKD)–associated cardiac arrest, a study found.
Managed Care Cast Logo
February 25th 2025

Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care

Pearl Steinzor Arthur L. Jenkins III, MD, FACS
On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Patients with PAH had distinct PA flow characteristics compared with those with PH-HFpEF. | Image credit: Thirawat - stock.adobe.com
March 21st 2025

Pulmonary Hypertension Subtypes Show Distinct PA Flow Hemodynamics

Jared Kaltwasser
Investigators used 4D flow cardiovascular magnetic resonance imaging to search for differences between pulmonary artery (PA) remodeling in pulmonary arterial hypertension and other types of pulmonary hypertension.
managed care cast logo
February 18th 2025

Varied Access: The Pharmacogenetic Testing Coverage Divide

Brooke McCormick Jai N. Patel, PharmD
On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
FDA Approval | image credit: PKartstudio - stock.adobe.com
March 21st 2025

FDA Approves Vutrisiran to Mitigate Cardiomyopathy-Related Risks and Conditions

Kyle Munz
In a recent decision, the FDA approved vutrisiran (amvuttra), making it the only approved therapy for adults with hereditary transthyretin-mediated amyloidosis (ATTR-CM) or wild-type cardiomyopathy.
Screenshot of an interview with Ajai Chari, MD
March 21st 2025

Streamlining "Brain-to-Vein" Time, Patient Selection, Imperative for Implementing CAR T for MM

Kyle Munz Ajai Chari, MD
Ajai Chari, MD, University of California San Francisco, explores the challenges that accompany integrating chimeric antigen receptor (CAR) T-cell therapies into multiple myeloma treatment.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo